Andrew A. Ziskind

PUBLIC-PRIVATE INTERFACE
Adjunct Professor of Health Enterprise Management

Print Overview

Andrew Ziskind is an Adjunct Professor of Health Enterprise Management at the Kellogg School of Management. He is a Managing Director at Huron Healthcare. He received his MD at the University of Pennsylvania School of Medicine, and his MBA at the Sellinger School of Business, Loyola College of Maryland.



Print Vita
Education
M.B.A., 1999, Sellinger School of Business, Loyola College of Maryland
M.D., 1984, School of Medicine, University of Pennsylvania
A.B., 1980, Bowdoin College, Bowdoin College

Academic Positions
Professor of Medicine, Washington University, 2005-2010

Other Professional Experience
Managing Director, Clinical Solutions, Huron Healthcare, 2012-present
Partner, Health and Public Services Group, Accenture, 2010-2011
Senior Vice-President for Health Care Reform, BJC Healthcare, 2009-2010
President, Barnes-Jewish West County Hospital, 2007-2009
Group President, BJC Healthcare, 2005-2009
President, Barnes-Jewish Hospital, 2005-2009
Vice Dean for Clinical Affairs, University of Washington, 1999-2005
Associate Vice President for Clinical Programs, University of Washington, 1999-2005
Vice-President for Clinical Services, UniversityCARE, University of Maryland, 1997-1999
Director, University of Maryland Cardiac Network, University of Maryland, 1995-1999
Director, Cardiac Catheterization Laboratory, University of Maryland, 1990-1995

Print Research

 
Print Teaching
Full-Time / Evening & Weekend MBA
Transformation of the US Healthcare Delivery System (HEMA-924-5)

**This course was formerly known as HEMA 924-A**

Health-care's transformation to population health will fundamentally change all health-related industries, including direct care providers, payers, healthcare technology companies, the pharma/device industry, and public policy. This course will address this fundamental shift in health care delivery, financing, use of data/analytics, patient engagement/activation, and emerging/innovative delivery models including advances in personalized medicine, biometrics and tele-health.

A basic understanding of the health care industry is suggested but not required.